Novel triazine compounds for treatment of cancer
Details for Australian Patent Application No. 2008270269 (hide)
International Classifications
Event Publications
28 January 2010 PCT application entered the National Phase
PCT publication WO2009/004060 Priority application(s): WO2009/004060
4 February 2010 Amendment Made
The nature of the amendment is: Amend the invention title to read Novel triazene compounds for the treatment of cancer
18 August 2011 Assignment before Grant
TriN Pharma GmbH The application has been assigned to TriN Therapeutics GmbH
12 April 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 04 Aug 2011 and 6 and 22 March 2012
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008270274-Providing improved immunoglobulin sequences by mutating CDR and/or FR positions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser